Literature DB >> 3871419

Mechanisms of in vivo generation of cytotoxic activity against syngeneic tumours. I. Local differentiation of mature cytotoxic T lymphocytes in the rejection of tumours.

S Tsuru, S Aiso, M Taniguchi, Y Zinnaka, K Nomoto.   

Abstract

Mature cytotoxic T lymphocytes (CTL) were detected in the peritoneal cavity of syngeneic mice immunized intraperitoneally (i.p.) with mitomycin C (MC)-treated EL-4 or X5563 cells, but were not found in their spleens or lymph nodes. Mature CTL appeared among PE cells after transfer of spleen cells from those immune mice, along with MC-treated tumour cells, to the peritoneal cavity of syngeneic mice. These results lead us to the hypothesis that immature CTL primed in the spleen and lymph nodes may migrate to the site of tumour inoculation and differentiate into mature CTL after antigenic or non-specific stimulation at that site. Inability of primed CTL to differentiate to mature CTL in the spleen might be explained by the effect of splenic suppressor cells, since mature CTL became detectable in the spleen of immune mice by treatment with cyclophosphamide.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3871419      PMCID: PMC1453505     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  11 in total

1.  Demonstration of resistance against methylcholanthrene-induced sarcomas in the primary autochthonous host.

Authors:  G KLEIN; H O SJOGREN; E KLEIN; K E HELLSTROM
Journal:  Cancer Res       Date:  1960-12       Impact factor: 12.701

2.  Antigenic properties of methylcholanthrene-induced tumors in mice of the strain of origin.

Authors:  E J FOLEY
Journal:  Cancer Res       Date:  1953-12       Impact factor: 12.701

3.  Poly-2-vinylpyridine N-oxide reverses the immunosuppressive effects of silica and carrageenan.

Authors:  A Rios; R L Simmons
Journal:  Transplantation       Date:  1972-03       Impact factor: 4.939

4.  Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs.

Authors:  K T Brunner; J Mauel; J C Cerottini; B Chapuis
Journal:  Immunology       Date:  1968-02       Impact factor: 7.397

5.  Surface properties and functional characteristics of infiltrating cells harvested from acutely rejecting cardiac allografts in inbred rats.

Authors:  N L Tilney; T B Strom; S G Macpherson; C B Carpenter
Journal:  Transplantation       Date:  1975-10       Impact factor: 4.939

6.  Mechanisms of in vivo generation of cytotoxic activity against allograft. I. Local differentiation of mature cytotoxic T lymphocytes in rejection of allogeneic lymphocytes.

Authors:  T Sakemi; A Kuroiwa; K Taniguchi; K Nomoto
Journal:  Cell Immunol       Date:  1980-09-01       Impact factor: 4.868

7.  Relationships among differentiated T-cell subpopulations. V. T-cell dependent mechanism of xenograft rejection and its radioresistant nature.

Authors:  R Terasaka; K Nomoto; K Himeno
Journal:  Immunology       Date:  1979-12       Impact factor: 7.397

8.  Immunity to lymphoid tumors in syngeneic mice by immunization with mitomycin C-treated cells.

Authors:  E Benjamini; S Fong; C Erickson; C Y Leung; D Rennick; R J Scibienski
Journal:  J Immunol       Date:  1977-02       Impact factor: 5.422

9.  Enhanced immunogenicity of chemically-coated syngeneic tumor cells.

Authors:  W J Martin; J R Wunderlich; F Fletcher; J K Inman
Journal:  Proc Natl Acad Sci U S A       Date:  1971-02       Impact factor: 11.205

10.  Cyclophosphamide-sensitive T lymphocytes suppress the in vivo generation of antigen-specific cytotoxic T lymphocytes.

Authors:  M Röllinghoff; A Starzinski-Powitz; K Pfizenmaier; H Wagner
Journal:  J Exp Med       Date:  1977-02-01       Impact factor: 14.307

View more
  2 in total

1.  Augmented induction of antitumor cells in vivo by cyclophosphamide fails to benefit antitumor resistance of the host.

Authors:  K Ryoyama; C Ryoyama
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

2.  Cyclophosphamide modifies the induction kinetics but not cell types and cytotoxic mechanisms of antitumor cells elicited with OK-432 plus attenuated tumor cells.

Authors:  K Ryoyama; C Ryoyama
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.